A study to evaluate the effect of Nimba Lodhra Eyedrops in Mucopurulent Conjunctivitis

An open labelled randomized controlled clinical study on the evaluation of efficacy of Nimba Lodra Kwatha Aschotana in Pittaja Abhishyanda, Infective Conjunctivitis - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072719

Enrollment

Registered

2024-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H100- Mucopurulent conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects above 18 years to below 60 years Subjects presenting with any 3 or 4 clinical features of the Pittaja abhishyanda.

Exclusion criteria

Exclusion criteria: Subjects presenting with the clinical features of the Vataja, Kaphaja, and Raktaja abhishyanda. Subjects with Conjunctivitis with Fungal infection, Kerato-conjunctivitis, Corneal ulcers, Dacryocystitis, Scleritis, Blepharitis, Trachoma. Subjects with systemic disease Specific conjunctivitis Tuberculous, Lepromatous Conjunctivitis.

Design outcomes

Primary

Measure	Time frame
Reduction in Neutrophils, mononuclear cells, eosinophils, mast cells, lymphocytes and presence of pathogens in conjunctival smear.Timepoint: 14 days	—

Secondary

Measure	Time frame
Reduction in Photophobia Reduction in Papillary reactionTimepoint: 14 days	—

Countries

India

Contacts

Public ContactDr Gavimath Shivanand

JSS Ayurveda Medical College and Hospital

shiva.shalakya@gmail.com7892395602

Outcome results